◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › OABI

OmniAb, Inc. (OABI) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-21

OmniAb, Inc. (OABI) operates in the Biotechnology industry and is headquartered in EmeryVille, United States with about 89 employees. Its market capitalization is roughly $302 million. In the fiscal year ended 2025-12-31, OABI reported $19M in revenue and ($65M) in net income.

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Interactive charts & full statements → Open the OABI valuation workbench →

OABI Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$19M$26M$34M$59M
Gross Profit$18M$26M
Operating Income (EBIT)($69M)($74M)($69M)($27M)
Net Income($65M)($62M)($51M)($22M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OABI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$14M$8M$2M$4M$4M
Gross Profit$14M$8M$2M$4M$4M
Operating Income (EBIT)($8M)($16M)($18M)($19M)($19M)
Net Income($8M)($14M)($16M)($16M)($18M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OABI Free Cash Flow History

OABI Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$301M$326M$375M$421M
Total Liabilities$34M$38M$61M$80M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OABI viewer.

Other Companies in Biotechnology

← OAll stocksOACC →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.